Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma

Aim. Sal-like protein 4 (SALL4), is reexpressed in tissues of a subgroup of HCC associated with poor prognosis. Reports of SALL4 serological levels linked to HCC patients are meager and unclear in the prognosis of this malignancy. Methods. Immunohistochemistry and optical microscopy protocols were u...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Su-xia, Wang, Jun-lan, Guo, Xi-jing, He, Chen-chen, Ying, Xia, Ma, Jin-lu, Zhang, Yuan-yuan, Zhao, Qian, Zhu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016881/
https://www.ncbi.nlm.nih.gov/pubmed/24860834
http://dx.doi.org/10.1155/2014/262385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016881/
https://www.ncbi.nlm.nih.gov/pubmed/24860834
http://dx.doi.org/10.1155/2014/262385

Ejemplares similares